loading

Adaptive Biotechnologies Corp Aktie (ADPT) Neueste Nachrichten

Insider Selling: ROBINS CHAD M, Adaptive Biotechnologies Corp [ADPT] CEO and Chairman divested 48673 shares ... - Knox Daily

pulisher
Knox Daily

ADPT Stock: A Comprehensive Analysis and Forecast - The InvestChronicle

pulisher
The InvestChronicle

Adaptive Biotechnologies (NASDAQ:ADPT) Trading Down 3.8% - MarketBeat

pulisher
MarketBeat

Versor Investments LP Grows Stock Holdings in Adaptive Biotechnologies Co. (NASDAQ:ADPT) - Defense World

pulisher
Defense World

Check Out Adaptive Biotechnologies Corp (ADPT)'s Trade Data Rather Than the Analysts' Views – Sete News - SETE News

pulisher
SETE News

Examining the Potential Price Growth of Adaptive Biotechnologies Corp (ADPT) – Knox Daily - Knox Daily

pulisher
Knox Daily

Replimune Group (NASDAQ:REPL) and Adaptive Biotechnologies (NASDAQ:ADPT) Financial Survey - Defense World

pulisher
Defense World

Earnings call: Adaptive Biotechnologies reports robust MRD growth - Investing.com

pulisher
Investing.com

Adaptive Biotechnologies (NASDAQ:ADPT) Shares Gap Up Following Strong Earnings - Defense World

pulisher
Defense World

Why Adaptive Biotechnologies Topped the Market Today

pulisher
The Motley Fool

Adaptive Biotechnologies (NASDAQ:ADPT) Announces Earnings Results - MarketBeat

pulisher
MarketBeat

Adaptive Biotechnologies Corporation (NASDAQ:ADPT) Q1 2024 Earnings Call Transcript - Insider Monkey

pulisher
Insider Monkey

Adaptive Biotechnologies Corporation (NASDAQ:ADPT) Q1 2024 Earnings Call Transcript - Insider Monkey

pulisher
Insider Monkey

Adaptive Biotechnologies (NASDAQ:ADPT) Announces Earnings Results - MarketBeat

pulisher
MarketBeat

Compared to Estimates, Adaptive Biotechnologies (ADPT) Q1 Earnings: A Look at Key Metrics - Yahoo Finance UK

pulisher
Yahoo Finance UK

Adaptive Biotechnologies: Q1 Earnings Snapshot - Houston Chronicle

pulisher
Houston Chronicle

Adaptive Biotechnologies (ADPT) Reports Q1 Loss, Misses Revenue Estimates

pulisher
Zacks Investment Research

Adaptive Biotechnologies Q1 2024 Earnings: Revenue Beats Estimates Amidst Challenges - GuruFocus.com

pulisher
GuruFocus.com

Adaptive Biotechnologies Reports First Quarter 2024 Financial Results - Yahoo Finance

pulisher
Yahoo Finance

Compared to Estimates, Adaptive Biotechnologies (ADPT) Q1 Earnings: A Look at Key Metrics - Yahoo Finance

pulisher
Yahoo Finance

ADPT (Adaptive Biotechnologies) Total Assets - GuruFocus.com

pulisher
GuruFocus.com

Top investors say Adaptive Biotechnologies Corp (ADPT) ticks everything they need – Sete News - SETE News

pulisher
SETE News

Adaptive Biotechnologies (ADPT) to Release Earnings on Tuesday - MarketBeat

pulisher
MarketBeat

A stock that deserves closer examination: Adaptive Biotechnologies Corp (ADPT) – US Post News - US Post News

pulisher
US Post News

Adaptive Biotechnologies Corp [ADPT] Insider Activity: An Update for Investors – Knox Daily - Knox Daily

pulisher
Knox Daily

Adaptive Biotechnologies Corp [NASDAQ: ADPT] Sees Decrease in Stock Value – Knox Daily - Knox Daily

pulisher
Knox Daily

Why Wang & Lee Group Shares Are Trading Higher By 38%; Here Are 20 Stocks Moving Premarket - Adaptive Bio - Benzinga

pulisher
Benzinga

Why Travelers Shares Are Trading Lower By Around 8%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session

pulisher
Benzinga

Why Travelers Shares Are Trading Lower By Around 8%? Here Are Other Stocks Moving In Wednesday’s Mid-Day - Benzinga

pulisher
Benzinga

Adaptive Biotechnologies names new CFO, restructures business lines - The Business Journals

pulisher
The Business Journals

Adaptive Biotechnologies Names Kyle Piskel New CFO - TipRanks.com - TipRanks

pulisher
TipRanks

Adaptive Biotechnologies Names New CFO Preserves Strong Capital Position

pulisher
Benzinga

It's Down 26% But Adaptive Biotechnologies Corporation (NASDAQ:ADPT) Could Be Riskier Than It Looks - Simply Wall St

pulisher
Simply Wall St

Adaptive Biotechnologies Provides Strategic Review Update and Announces Preliminary First Quarter 2024 Revenue

pulisher
GlobeNewswire Inc.

Adaptive Biotechnologies CFO Resigns, Successor Appointed - TipRanks.com - TipRanks

pulisher
TipRanks

5 Biotech Stocks With 26% Upside Potential Or More - Barchart

pulisher
Barchart

Adaptive Biotechnologies to Present at the TD Cowen 44th Annual Healthcare Conference

pulisher
GlobeNewswire Inc.

Adaptive Biotechnologies Reports Fourth Quarter and Full Year 2023 Financial Results

pulisher
GlobeNewswire Inc.

Adaptive Biotechnologies Reports Fourth Quarter and Full Year 2023 Financial Results - Yahoo Finance

pulisher
Yahoo Finance

Here's Why Adaptive Biotechnologies Corporation (ADPT) Declined in Q4 - Yahoo Finance

pulisher
Yahoo Finance

Exploring Analyst Estimates for Adaptive Biotechnologies (ADPT) Q4 Earnings, Beyond Revenue and EPS

pulisher
Zacks Investment Research

Adaptive Biotechnologies to Report Fourth Quarter and Full Year 2023 Financial Results on February 14, 2024

pulisher
GlobeNewswire Inc.

Adaptive Biotechnologies to Report Fourth Quarter and Full Year 2023 Financial Results on February 14, 2024 - Yahoo Finance

pulisher
Yahoo Finance

Adaptive Biotechnologies to Present at the 42nd Annual J.P. Morgan Healthcare Conference

pulisher
GlobeNewswire Inc.

Cathie Wood's Ark Invest Sells Nearly $11.5M Worth Of Coinbase Shares As Bitcoin, Crypto Rally Loses Steam

pulisher
Benzinga

Cathie Wood Is Loading Up on These 3 Small-Cap Stocks: Should You?

pulisher
The Motley Fool

Cathie Wood's Ark Dumps $12.8M Worth Of Grayscale Bitcoin Trust Amid Crypto Rally Losing Wind In Sails

pulisher
Benzinga

Adaptive Biotechnologies Announces New Data Highlighting the Clinical Relevance of MRD Testing with clonoSEQ® in Patients with Blood Cancers at the 65th ASH Annual Meeting

pulisher
GlobeNewswire Inc.

Cathie Wood's Ark Invest Trims Bitcoin Exposure, Sells $2.9M Worth Of GBTC Shares Amid Crypto Market Volatility

pulisher
Benzinga

Adaptive Biotechnologies and Collaborators to Present More than 30 Abstracts Demonstrating the Actionability of clonoSEQ® MRD Testing in Blood Cancer Patient Care and Drug Development at the 65th ASH Annual Meeting

pulisher
GlobeNewswire Inc.
$77.56
price up icon 0.77%
$149.40
price down icon 1.20%
$29.98
price up icon 1.11%
$172.85
price up icon 1.06%
$365.81
price down icon 2.87%
$90.61
price down icon 2.55%
Kapitalisierung:     |  Volumen (24h):